-
Product Insights
Leiomyoma – Drugs In Development, 2023
Global Markets Direct’s, ‘Leiomyoma - Drugs In Development, 2023’, provides an overview of the Leiomyoma pipeline landscape. The report provides comprehensive information on the therapeutics under development for Leiomyoma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Nasopharyngitis (Common Cold) – Drugs In Development, 2023
Global Markets Direct’s, ‘Nasopharyngitis (Common Cold) - Drugs In Development, 2023’, provides an overview of the Nasopharyngitis (Common Cold) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Nasopharyngitis (Common Cold), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Deep Vein Thrombosis (DVT) – Drugs In Development, 2023
Global Markets Direct’s, ‘Deep Vein Thrombosis (DVT) - Drugs In Development, 2023’, provides an overview of the Deep Vein Thrombosis (DVT) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Deep Vein Thrombosis (DVT), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Product Insights
Uterine Leiomyoma (Uterine Fibroids) – Drugs In Development, 2023
Global Markets Direct’s, ‘Uterine Leiomyoma (Uterine Fibroids) - Drugs In Development, 2023’, provides an overview of the Uterine Leiomyoma (Uterine Fibroids) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Uterine Leiomyoma (Uterine Fibroids), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Product Insights
Venous (Vein) Thrombosis – Drugs In Development, 2023
Global Markets Direct’s, ‘Venous (Vein) Thrombosis - Drugs In Development, 2023’, provides an overview of the Venous (Vein) Thrombosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Venous (Vein) Thrombosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Idiopathic (Essential) Hypertension – Drugs In Development, 2023
Global Markets Direct’s, ‘Idiopathic (Essential) Hypertension - Drugs In Development, 2023’, provides an overview of the Idiopathic (Essential) Hypertension pipeline landscape. The report provides comprehensive information on the therapeutics under development for Idiopathic (Essential) Hypertension, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Ocular Hypertension – Drugs In Development, 2023
Global Markets Direct’s, ‘Ocular Hypertension - Drugs In Development, 2023’, provides an overview of the Ocular Hypertension pipeline landscape. The report provides comprehensive information on the therapeutics under development for Ocular Hypertension, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Thromboembolism – Drugs In Development, 2023
Global Markets Direct’s, ‘Thromboembolism - Drugs In Development, 2023’, provides an overview of the Thromboembolism pipeline landscape. The report provides comprehensive information on the therapeutics under development for Thromboembolism, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Venous Thromboembolism – Drugs In Development, 2023
Global Markets Direct’s, ‘Venous Thromboembolism - Drugs In Development, 2023’, provides an overview of the Venous Thromboembolism pipeline landscape. The report provides comprehensive information on the therapeutics under development for Venous Thromboembolism, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Alcohol Addiction – Drugs In Development, 2023
Global Markets Direct’s, ‘Alcohol Addiction - Drugs In Development, 2023’, provides an overview of the Alcohol Addiction pipeline landscape. The report provides comprehensive information on the therapeutics under development for Alcohol Addiction, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...